U.S. Markets open in 7 hrs 4 mins

Corcept Therapeutics Incorporated (CORT)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
11.69-0.67 (-5.42%)
At close: 4:00PM EDT
People also watch
CYTKCRISGTXIFOLDDVAX
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue81,32150,28626,551
Cost of Revenue2,0581,361882
Gross Profit79,26348,92525,669
Operating Expenses
Research Development23,84415,41918,372
Selling General and Administrative45,24036,94934,916
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss10,179-3,443-27,619
Income from Continuing Operations
Total Other Income/Expenses Net---
Earnings Before Interest and Taxes10,179-3,443-27,619
Interest Expense2,0392,9653,764
Income Before Tax8,140-6,408-31,383
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops8,140-6,408-31,383
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income8,140-6,408-31,383
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares8,140-6,408-31,383